Sun Pharma profit falls on Organon deal costs; specialty drug sales remain strong
Sun Pharma said profit fell due to costs from its Organon transaction, while specialty drug sales remained strong.
Sun Pharma said profit fell due to costs from its Organon transaction, while specialty drug sales remained strong.